Pulse Biosciences, Inc (PLSE): Price and Financial Metrics


Pulse Biosciences, Inc (PLSE): $1.52

-0.01 (-0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PLSE Stock Price Chart Interactive Chart >

Price chart for PLSE

PLSE Price/Volume Stats

Current price $1.52 52-week high $29.16
Prev. close $1.53 52-week low $1.41
Day low $1.50 Volume 227,600
Day high $1.61 Avg. volume 215,606
50-day MA $2.21 Dividend yield N/A
200-day MA $10.89 Market Cap 45.30M

Pulse Biosciences, Inc (PLSE) Company Bio


Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.


PLSE Latest News Stream


Event/Time News Detail
Loading, please wait...

PLSE Latest Social Stream


Loading social stream, please wait...

View Full PLSE Social Stream

Latest PLSE News From Around the Web

Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.

DEADLINE: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

SAN DIEGO, Feb. 19, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Pulse Biosciences, Inc. (NASDAQ: PLSE) securities between January 12, 2021 and February 7, 2022, inclusive (the "Class Period") have until April 18, 2022 to seek

PR Newswire | February 19, 2022

Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)---- $PLSE #attorney--Pulse Biosciences, Inc. (PLSE) Misstated the Viability of its CellFX System for Treating Sebaceous Hyperplasia Lesions

Business Wire | February 18, 2022

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $PLSE #PLSE--The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Business Wire | February 18, 2022

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE

NEW YORK--(BUSINESS WIRE)---- $PLSE #PLSE--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 through February 7, 2022, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 18, 2022. SO WHAT: If you purchased Pulse securities during the Class P

Business Wire | February 18, 2022

ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

SAN DIEGO--(BUSINESS WIRE)-- #PLSEstock--The suit alleges defendants issued false statements re: Pulse Biosciences business & prospects, resulting in its stock trading at inflated prices.

Business Wire | February 17, 2022

Read More 'PLSE' Stories Here

PLSE Price Returns

1-mo -28.30%
3-mo -57.18%
6-mo -89.72%
1-year -91.19%
3-year -88.52%
5-year -95.02%
YTD -89.74%
2021 -37.93%
2020 77.93%
2019 17.02%
2018 -51.44%
2017 263.08%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4578 seconds.